| 0 |
SMOOTH MUSCLE CELL NEOPLASM |
296 |
0.7081 |
| 1 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
1503 |
0.6409 |
| 2 |
TRICHODYSPLASIA SPINULOSA |
242 |
0.6352 |
| 3 |
RENAL GRAFT INFECTION |
145 |
0.6250 |
| 4 |
TRANSPLANT DYSFUNCTION |
1068 |
0.5980 |
| 5 |
GRIP STRENGTH |
135 |
0.5895 |
| 6 |
MALACOPLAKIA |
263 |
0.5742 |
| 7 |
POLYOMAVIRUS VIRAEMIA |
594 |
0.5593 |
| 8 |
CHRONIC ALLOGRAFT NEPHROPATHY |
435 |
0.5556 |
| 9 |
DELAYED GRAFT FUNCTION |
394 |
0.5541 |
| 10 |
C-REACTIVE PROTEIN |
505 |
0.5448 |
| 11 |
HEART TRANSPLANT REJECTION |
560 |
0.5395 |
| 12 |
PHAEOHYPHOMYCOSIS |
257 |
0.5365 |
| 13 |
MYCOBACTERIUM HAEMOPHILUM INFECTION |
149 |
0.5210 |
| 14 |
TRANSPLANT REJECTION |
4167 |
0.5196 |
| 15 |
SWOLLEN JOINT COUNT |
127 |
0.5080 |
| 16 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
976 |
0.4873 |
| 17 |
PARVOVIRUS B19 INFECTION |
433 |
0.4838 |
| 18 |
COMPLICATIONS OF TRANSPLANTED HEART |
100 |
0.4651 |
| 19 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
2342 |
0.4597 |
| 20 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
1041 |
0.4586 |
| 21 |
HUMAN POLYOMAVIRUS INFECTION |
243 |
0.4576 |
| 22 |
ALTERNARIA INFECTION |
170 |
0.4570 |
| 23 |
BK VIRUS INFECTION |
1497 |
0.4434 |
| 24 |
LUPUS VULGARIS |
553 |
0.4389 |
| 25 |
RENAL TRANSPLANT FAILURE |
431 |
0.4362 |
| 26 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
390 |
0.4212 |
| 27 |
GRAFT LOSS |
295 |
0.4069 |
| 28 |
COMPLICATIONS OF TRANSPLANTED LUNG |
124 |
0.4039 |
| 29 |
GRAFT DYSFUNCTION |
114 |
0.4000 |
| 30 |
KIDNEY TRANSPLANT REJECTION |
1912 |
0.3981 |
| 31 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
551 |
0.3900 |
| 32 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
1073 |
0.3878 |
| 33 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
277 |
0.3853 |
| 34 |
PULMONARY MUCORMYCOSIS |
203 |
0.3845 |
| 35 |
LUNG TRANSPLANT REJECTION |
252 |
0.3818 |
| 36 |
MICROTIA |
120 |
0.3810 |
| 37 |
CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION |
113 |
0.3792 |
| 38 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER |
138 |
0.3791 |
| 39 |
HUMAN HERPESVIRUS 8 INFECTION |
228 |
0.3744 |
| 40 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
790 |
0.3709 |
| 41 |
CYSTITIS VIRAL |
142 |
0.3708 |
| 42 |
SWOLLEN JOINT COUNT INCREASED |
1183 |
0.3706 |
| 43 |
CYTOMEGALOVIRUS VIRAEMIA |
1577 |
0.3541 |
| 44 |
CRYPTOSPORIDIOSIS INFECTION |
185 |
0.3524 |
| 45 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY |
232 |
0.3473 |
| 46 |
DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION |
125 |
0.3444 |
| 47 |
VIRAL HAEMORRHAGIC CYSTITIS |
240 |
0.3371 |
| 48 |
GRAFT VERSUS HOST DISEASE IN SKIN |
738 |
0.3347 |
| 49 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
1480 |
0.3347 |
| 50 |
EPSTEIN-BARR VIRAEMIA |
368 |
0.3318 |
| 51 |
CYTOMEGALOVIRUS OESOPHAGITIS |
120 |
0.3261 |
| 52 |
CHRONIC GRAFT VERSUS HOST DISEASE |
1174 |
0.3248 |
| 53 |
ADENOVIRUS INFECTION |
943 |
0.3248 |
| 54 |
LYMPHOCELE |
215 |
0.3238 |
| 55 |
RETINITIS |
559 |
0.3233 |
| 56 |
ACUTE GRAFT VERSUS HOST DISEASE |
1468 |
0.3204 |
| 57 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
660 |
0.3182 |
| 58 |
GRAFT VERSUS HOST DISEASE IN LUNG |
152 |
0.3180 |
| 59 |
LIVER TRANSPLANT REJECTION |
568 |
0.3159 |
| 60 |
PULMONARY NOCARDIOSIS |
259 |
0.3143 |
| 61 |
TRANSPLANT FAILURE |
770 |
0.3138 |
| 62 |
CEREBRAL TOXOPLASMOSIS |
291 |
0.3116 |
| 63 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
1026 |
0.3103 |
| 64 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
361 |
0.3008 |
| 65 |
CYTOMEGALOVIRUS INFECTION |
5001 |
0.3006 |
| 66 |
RHEUMATIC FEVER |
1328 |
0.2976 |
| 67 |
MICROSPORIDIA INFECTION |
103 |
0.2934 |
| 68 |
RENAL TUBULAR ATROPHY |
256 |
0.2902 |
| 69 |
BLASTOMYCOSIS |
140 |
0.2881 |
| 70 |
DISSEMINATED CRYPTOCOCCOSIS |
217 |
0.2867 |
| 71 |
GRAFT VERSUS HOST DISEASE IN LIVER |
204 |
0.2849 |
| 72 |
CYTOMEGALOVIRUS ENTERITIS |
100 |
0.2809 |
| 73 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA |
166 |
0.2809 |
| 74 |
DISSEMINATED MUCORMYCOSIS |
109 |
0.2766 |
| 75 |
LUPUS NEPHRITIS |
514 |
0.2746 |
| 76 |
FACET JOINT SYNDROME |
883 |
0.2709 |
| 77 |
CAT SCRATCH DISEASE |
107 |
0.2662 |
| 78 |
EPSTEIN-BARR VIRUS INFECTION |
1661 |
0.2656 |
| 79 |
CYTOMEGALOVIRUS COLITIS |
603 |
0.2619 |
| 80 |
SCEDOSPORIUM INFECTION |
183 |
0.2592 |
| 81 |
DISLOCATION OF VERTEBRA |
590 |
0.2584 |
| 82 |
VARICELLA ZOSTER VIRUS INFECTION |
531 |
0.2559 |
| 83 |
INFECTION REACTIVATION |
293 |
0.2559 |
| 84 |
X-RAY ABNORMAL |
456 |
0.2547 |
| 85 |
WEST NILE VIRAL INFECTION |
190 |
0.2533 |
| 86 |
UREAPLASMA INFECTION |
102 |
0.2500 |
| 87 |
HUMAN HERPESVIRUS 6 INFECTION |
466 |
0.2463 |
| 88 |
TOXOPLASMOSIS |
266 |
0.2463 |
| 89 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
426 |
0.2408 |
| 90 |
PNEUMONIA CYTOMEGALOVIRAL |
467 |
0.2402 |
| 91 |
OVERLAP SYNDROME |
167 |
0.2386 |
| 92 |
JC VIRUS INFECTION |
378 |
0.2362 |
| 93 |
MUCORMYCOSIS |
608 |
0.2338 |
| 94 |
NOCARDIOSIS |
597 |
0.2332 |
| 95 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
360 |
0.2246 |
| 96 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
293 |
0.2225 |
| 97 |
RENAL TUBULAR INJURY |
270 |
0.2222 |
| 98 |
CRYPTOCOCCOSIS |
361 |
0.2213 |
| 99 |
VIRAEMIA |
305 |
0.2201 |
| 100 |
HISTOPLASMOSIS DISSEMINATED |
348 |
0.2191 |
| 101 |
STRONGYLOIDIASIS |
347 |
0.2146 |
| 102 |
RHEUMATOID FACTOR POSITIVE |
1236 |
0.2138 |
| 103 |
GRAFT COMPLICATION |
122 |
0.2078 |
| 104 |
MENINGITIS CRYPTOCOCCAL |
351 |
0.2006 |
| 105 |
GRAFT VERSUS HOST DISEASE |
1443 |
0.2005 |
| 106 |
GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE |
104 |
0.1985 |
| 107 |
DUODENAL ULCER PERFORATION |
1474 |
0.1980 |
| 108 |
INFECTION IN AN IMMUNOCOMPROMISED HOST |
141 |
0.1964 |
| 109 |
HEPATITIS E |
310 |
0.1962 |
| 110 |
CYTOMEGALOVIRUS TEST POSITIVE |
345 |
0.1934 |
| 111 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
266 |
0.1929 |
| 112 |
STENOTROPHOMONAS INFECTION |
260 |
0.1916 |
| 113 |
KIDNEY FIBROSIS |
332 |
0.1912 |
| 114 |
C-REACTIVE PROTEIN ABNORMAL |
1190 |
0.1853 |
| 115 |
PNEUMOCYSTIS JIROVECII INFECTION |
219 |
0.1833 |
| 116 |
ENCEPHALITIS VIRAL |
223 |
0.1831 |
| 117 |
THROMBOTIC MICROANGIOPATHY |
1749 |
0.1793 |
| 118 |
EPSTEIN-BARR VIRUS TEST POSITIVE |
112 |
0.1775 |
| 119 |
SYSTEMIC MYCOSIS |
205 |
0.1755 |
| 120 |
CYSTITIS HAEMORRHAGIC |
700 |
0.1735 |
| 121 |
OBLITERATIVE BRONCHIOLITIS |
225 |
0.1714 |
| 122 |
ATYPICAL HAEMOLYTIC URAEMIC SYNDROME |
138 |
0.1697 |
| 123 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
1103 |
0.1697 |
| 124 |
ALVEOLAR PROTEINOSIS |
100 |
0.1689 |
| 125 |
URETERIC STENOSIS |
135 |
0.1685 |
| 126 |
ASPERGILLUS INFECTION |
1101 |
0.1676 |
| 127 |
KLEBSIELLA INFECTION |
848 |
0.1675 |
| 128 |
PORPHYRIA ACUTE |
234 |
0.1631 |
| 129 |
MYCOBACTERIUM CHELONAE INFECTION |
119 |
0.1610 |
| 130 |
MYCOPLASMA INFECTION |
125 |
0.1601 |
| 131 |
BRAIN ABSCESS |
403 |
0.1591 |
| 132 |
ACINETOBACTER INFECTION |
172 |
0.1571 |
| 133 |
BONE EROSION |
555 |
0.1568 |
| 134 |
SERONEGATIVE ARTHRITIS |
178 |
0.1553 |
| 135 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
1105 |
0.1541 |
| 136 |
FUSARIUM INFECTION |
105 |
0.1500 |
| 137 |
VISCERAL LEISHMANIASIS |
108 |
0.1496 |
| 138 |
ENTEROCOCCAL INFECTION |
723 |
0.1495 |
| 139 |
MUSCLE INJURY |
1209 |
0.1458 |
| 140 |
MYCOBACTERIUM ABSCESSUS INFECTION |
104 |
0.1455 |
| 141 |
CYTOMEGALOVIRUS CHORIORETINITIS |
283 |
0.1450 |
| 142 |
HELICOBACTER INFECTION |
1491 |
0.1449 |
| 143 |
KLEBSIELLA BACTERAEMIA |
137 |
0.1442 |
| 144 |
MYCOBACTERIAL INFECTION |
248 |
0.1439 |
| 145 |
ENTEROCOCCAL BACTERAEMIA |
152 |
0.1434 |
| 146 |
APLASIA PURE RED CELL |
482 |
0.1400 |
| 147 |
HISTOPLASMOSIS |
246 |
0.1388 |
| 148 |
PNEUMONIA CRYPTOCOCCAL |
129 |
0.1365 |
| 149 |
VACCINATION FAILURE |
227 |
0.1364 |
| 150 |
FOLLICULITIS |
1428 |
0.1360 |
| 151 |
BRONCHOPULMONARY ASPERGILLOSIS |
1044 |
0.1345 |
| 152 |
HERPES ZOSTER DISSEMINATED |
108 |
0.1345 |
| 153 |
PERIPHERAL VENOUS DISEASE |
548 |
0.1341 |
| 154 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
1271 |
0.1265 |
| 155 |
GASTROENTERITIS NOROVIRUS |
168 |
0.1264 |
| 156 |
SUPERINFECTION BACTERIAL |
100 |
0.1261 |
| 157 |
PEMPHIGUS |
1578 |
0.1261 |
| 158 |
MICROANGIOPATHIC HAEMOLYTIC ANAEMIA |
99 |
0.1256 |
| 159 |
ENTEROBACTER INFECTION |
210 |
0.1249 |
| 160 |
URINARY TRACT INFECTION ENTEROCOCCAL |
114 |
0.1221 |
| 161 |
LIP DRY |
1081 |
0.1189 |
| 162 |
STEROID DEPENDENCE |
103 |
0.1173 |
| 163 |
HAND DEFORMITY |
1520 |
0.1158 |
| 164 |
ENTEROVIRUS INFECTION |
99 |
0.1146 |
| 165 |
PSEUDOMONAS INFECTION |
983 |
0.1145 |
| 166 |
BLOOD PRESSURE DIASTOLIC ABNORMAL |
291 |
0.1143 |
| 167 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
1089 |
0.1140 |
| 168 |
IGA NEPHROPATHY |
189 |
0.1139 |
| 169 |
AUTOIMMUNE DISORDER |
1095 |
0.1122 |
| 170 |
ANOGENITAL WARTS |
100 |
0.1121 |
| 171 |
PNEUMONIA KLEBSIELLA |
206 |
0.1120 |
| 172 |
STEROID DIABETES |
166 |
0.1106 |
| 173 |
HYPOGAMMAGLOBULINAEMIA |
715 |
0.1087 |
| 174 |
GLOMERULONEPHRITIS |
266 |
0.1086 |
| 175 |
HAEMOLYTIC URAEMIC SYNDROME |
249 |
0.1073 |
| 176 |
BLOOD IRON ABNORMAL |
104 |
0.1064 |
| 177 |
AMAUROSIS FUGAX |
114 |
0.1058 |
| 178 |
BREAST CANCER STAGE III |
681 |
0.1050 |
| 179 |
PNEUMATOSIS INTESTINALIS |
298 |
0.1044 |
| 180 |
NOROVIRUS INFECTION |
149 |
0.1032 |
| 181 |
BACTERIAL SEPSIS |
336 |
0.1031 |
| 182 |
VENOOCCLUSIVE LIVER DISEASE |
507 |
0.1026 |
| 183 |
SYSTEMIC CANDIDA |
257 |
0.1023 |
| 184 |
KLEBSIELLA SEPSIS |
115 |
0.1020 |
| 185 |
ATYPICAL MYCOBACTERIAL INFECTION |
144 |
0.1018 |
| 186 |
PAPILLOMA VIRAL INFECTION |
168 |
0.1018 |
| 187 |
GINGIVAL HYPERTROPHY |
154 |
0.1014 |
| 188 |
WOUND INFECTION |
1112 |
0.1014 |
| 189 |
SCIATICA |
1610 |
0.1009 |
| 190 |
ASPERGILLOSIS |
131 |
0.1002 |
| 191 |
JOINT RANGE OF MOTION DECREASED |
1336 |
0.0995 |
| 192 |
ESCHERICHIA INFECTION |
816 |
0.0991 |
| 193 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
210 |
0.0977 |
| 194 |
PYELONEPHRITIS ACUTE |
191 |
0.0973 |
| 195 |
CUSHINGOID |
307 |
0.0955 |
| 196 |
VENOOCCLUSIVE DISEASE |
237 |
0.0946 |
| 197 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
709 |
0.0944 |
| 198 |
DIFFUSE LARGE B-CELL LYMPHOMA |
719 |
0.0932 |
| 199 |
NEPHROPATHY TOXIC |
1044 |
0.0929 |
| 200 |
LYMPHOPROLIFERATIVE DISORDER |
273 |
0.0929 |
| 201 |
ACTINIC KERATOSIS |
240 |
0.0924 |
| 202 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
244 |
0.0917 |
| 203 |
CENTRAL NERVOUS SYSTEM INFECTION |
105 |
0.0916 |
| 204 |
SYNOVITIS |
1645 |
0.0911 |
| 205 |
RENAL ARTERY STENOSIS |
124 |
0.0899 |
| 206 |
DRUG TOLERANCE DECREASED |
252 |
0.0896 |
| 207 |
BLOOD PRESSURE SYSTOLIC ABNORMAL |
220 |
0.0889 |
| 208 |
PNEUMONIA PSEUDOMONAL |
132 |
0.0860 |
| 209 |
FUNGAEMIA |
135 |
0.0857 |
| 210 |
HERPES SIMPLEX |
555 |
0.0853 |
| 211 |
PARAINFLUENZAE VIRUS INFECTION |
129 |
0.0847 |
| 212 |
PERICARDITIS |
1414 |
0.0841 |
| 213 |
PNEUMONIA FUNGAL |
330 |
0.0836 |
| 214 |
TRANSITIONAL CELL CARCINOMA |
108 |
0.0832 |
| 215 |
DISSEMINATED TUBERCULOSIS |
212 |
0.0826 |
| 216 |
BILE DUCT STENOSIS |
98 |
0.0817 |
| 217 |
NEPHROTIC SYNDROME |
554 |
0.0807 |
| 218 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
2194 |
0.0774 |
| 219 |
SQUAMOUS CELL CARCINOMA OF SKIN |
458 |
0.0758 |
| 220 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
624 |
0.0756 |
| 221 |
ENCEPHALITIS AUTOIMMUNE |
99 |
0.0753 |
| 222 |
SOFT TISSUE INFECTION |
137 |
0.0748 |
| 223 |
NORMOCYTIC ANAEMIA |
109 |
0.0741 |
| 224 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
278 |
0.0739 |
| 225 |
GRIP STRENGTH DECREASED |
651 |
0.0739 |
| 226 |
HYPERCHOLESTEROLAEMIA |
712 |
0.0737 |
| 227 |
URINARY TRACT INFECTION BACTERIAL |
186 |
0.0735 |
| 228 |
LIVE BIRTH |
614 |
0.0733 |
| 229 |
ESCHERICHIA BACTERAEMIA |
172 |
0.0731 |
| 230 |
RENAL TUBULAR NECROSIS |
708 |
0.0721 |
| 231 |
OPPORTUNISTIC INFECTION |
130 |
0.0702 |
| 232 |
SCLERODERMA |
255 |
0.0701 |
| 233 |
FUNGAL SKIN INFECTION |
283 |
0.0700 |
| 234 |
REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME |
138 |
0.0698 |
| 235 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
2449 |
0.0689 |
| 236 |
BACTERAEMIA |
812 |
0.0684 |
| 237 |
INFECTIOUS PLEURAL EFFUSION |
103 |
0.0676 |
| 238 |
ESCHERICHIA SEPSIS |
196 |
0.0676 |
| 239 |
PNEUMOMEDIASTINUM |
122 |
0.0674 |
| 240 |
GLOSSODYNIA |
1506 |
0.0672 |
| 241 |
DERMATOMYOSITIS |
167 |
0.0659 |
| 242 |
STAPHYLOCOCCAL BACTERAEMIA |
286 |
0.0657 |
| 243 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
727 |
0.0656 |
| 244 |
BURSITIS |
795 |
0.0655 |
| 245 |
IRRITABLE BOWEL SYNDROME |
1393 |
0.0649 |
| 246 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1137 |
0.0642 |
| 247 |
RENAL TUBULAR ACIDOSIS |
140 |
0.0641 |
| 248 |
VARICELLA |
153 |
0.0640 |
| 249 |
FIBROMYALGIA |
1541 |
0.0633 |
| 250 |
RHINOVIRUS INFECTION |
244 |
0.0626 |
| 251 |
PYELONEPHRITIS |
538 |
0.0620 |
| 252 |
COVID-19 PNEUMONIA |
733 |
0.0620 |
| 253 |
ESCHERICHIA URINARY TRACT INFECTION |
263 |
0.0618 |
| 254 |
LOWER LIMB FRACTURE |
1179 |
0.0613 |
| 255 |
PROTEINURIA |
1164 |
0.0612 |
| 256 |
PULMONARY FIBROSIS |
1171 |
0.0610 |
| 257 |
RENAL TRANSPLANT |
217 |
0.0600 |
| 258 |
ORGANISING PNEUMONIA |
294 |
0.0593 |
| 259 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
156 |
0.0581 |
| 260 |
PNEUMONIA BACTERIAL |
520 |
0.0566 |
| 261 |
HISTIOCYTOSIS HAEMATOPHAGIC |
167 |
0.0562 |
| 262 |
SEPTIC SHOCK |
2447 |
0.0562 |
| 263 |
WOUND |
1550 |
0.0554 |
| 264 |
PNEUMOPERITONEUM |
102 |
0.0552 |
| 265 |
LIVER INJURY |
1352 |
0.0550 |
| 266 |
RENAL TUBULAR DISORDER |
153 |
0.0543 |
| 267 |
LUPUS-LIKE SYNDROME |
489 |
0.0539 |
| 268 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
182 |
0.0530 |
| 269 |
PNEUMONIA VIRAL |
168 |
0.0526 |
| 270 |
LUNG ABSCESS |
110 |
0.0524 |
| 271 |
LIVER ABSCESS |
170 |
0.0524 |
| 272 |
PRESCRIBED OVERDOSE |
1013 |
0.0523 |
| 273 |
EMPYEMA |
104 |
0.0523 |
| 274 |
EXOSTOSIS |
473 |
0.0517 |
| 275 |
ENCEPHALITIS |
355 |
0.0513 |
| 276 |
HAEMATOLOGICAL INFECTION |
125 |
0.0511 |
| 277 |
HYDRONEPHROSIS |
377 |
0.0503 |
| 278 |
IMPAIRED HEALING |
1641 |
0.0499 |
| 279 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
242 |
0.0485 |
| 280 |
LEUKOPENIA |
2418 |
0.0483 |
| 281 |
WOUND DEHISCENCE |
163 |
0.0482 |
| 282 |
TYPE 2 DIABETES MELLITUS |
1621 |
0.0481 |
| 283 |
LYMPHOPENIA |
677 |
0.0478 |
| 284 |
RED BLOOD CELL SEDIMENTATION RATE ABNORMAL |
110 |
0.0477 |
| 285 |
NEPHROGENIC SYSTEMIC FIBROSIS |
144 |
0.0476 |
| 286 |
B-CELL LYMPHOMA |
161 |
0.0474 |
| 287 |
HEPATIC FIBROSIS |
162 |
0.0472 |
| 288 |
FIBROSIS |
145 |
0.0471 |
| 289 |
PATHOGEN RESISTANCE |
429 |
0.0470 |
| 290 |
HEPATITIS B REACTIVATION |
149 |
0.0469 |
| 291 |
PULMONARY ALVEOLAR HAEMORRHAGE |
263 |
0.0468 |
| 292 |
PULMONARY TUBERCULOSIS |
200 |
0.0468 |
| 293 |
OBESITY |
745 |
0.0467 |
| 294 |
WALKING AID USER |
308 |
0.0467 |
| 295 |
SERUM SICKNESS |
129 |
0.0462 |
| 296 |
BRONCHIECTASIS |
311 |
0.0461 |
| 297 |
CLOSTRIDIUM DIFFICILE COLITIS |
488 |
0.0460 |
| 298 |
BLOOD IMMUNOGLOBULIN G DECREASED |
114 |
0.0460 |
| 299 |
APLASTIC ANAEMIA |
239 |
0.0457 |
| 300 |
ENDOCARDITIS |
231 |
0.0450 |
| 301 |
THERAPY NON-RESPONDER |
2024 |
0.0450 |
| 302 |
ARTHRITIS BACTERIAL |
183 |
0.0445 |
| 303 |
PSORIATIC ARTHROPATHY |
1807 |
0.0445 |
| 304 |
ABDOMINAL INFECTION |
111 |
0.0434 |
| 305 |
SQUAMOUS CELL CARCINOMA |
404 |
0.0429 |
| 306 |
MYASTHENIA GRAVIS |
346 |
0.0428 |
| 307 |
DRUG LEVEL INCREASED |
703 |
0.0424 |
| 308 |
PRESCRIBED UNDERDOSE |
845 |
0.0423 |
| 309 |
GRANULOMA |
146 |
0.0421 |
| 310 |
LUNG CONSOLIDATION |
117 |
0.0418 |
| 311 |
STAPHYLOCOCCAL SEPSIS |
206 |
0.0417 |
| 312 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
158 |
0.0413 |
| 313 |
CANDIDA INFECTION |
691 |
0.0409 |
| 314 |
OESOPHAGEAL CANDIDIASIS |
163 |
0.0409 |
| 315 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2244 |
0.0409 |
| 316 |
GROWTH RETARDATION |
120 |
0.0407 |
| 317 |
AGRANULOCYTOSIS |
755 |
0.0406 |
| 318 |
OVARIAN CYST |
406 |
0.0406 |
| 319 |
IMMUNOSUPPRESSION |
354 |
0.0401 |
| 320 |
JOINT DISLOCATION |
422 |
0.0399 |
| 321 |
LARGE INTESTINAL ULCER |
108 |
0.0397 |
| 322 |
HEPATOSPLENOMEGALY |
102 |
0.0397 |
| 323 |
HEPATIC NECROSIS |
149 |
0.0395 |
| 324 |
ENTERITIS |
252 |
0.0393 |
| 325 |
SKIN PAPILLOMA |
157 |
0.0391 |
| 326 |
THERAPY PARTIAL RESPONDER |
607 |
0.0389 |
| 327 |
IMMUNE THROMBOCYTOPENIA |
178 |
0.0388 |
| 328 |
HERPES VIRUS INFECTION |
222 |
0.0385 |
| 329 |
UROSEPSIS |
354 |
0.0383 |
| 330 |
LEUKOENCEPHALOPATHY |
142 |
0.0381 |
| 331 |
MYOPATHY |
329 |
0.0381 |
| 332 |
BACTERIAL INFECTION |
709 |
0.0380 |
| 333 |
CHOLANGITIS |
235 |
0.0379 |
| 334 |
OLIGURIA |
235 |
0.0378 |
| 335 |
HYPERVOLAEMIA |
187 |
0.0378 |
| 336 |
SUSPECTED OFF LABEL USE |
169 |
0.0374 |
| 337 |
HEPATITIS C |
451 |
0.0373 |
| 338 |
NECROTISING FASCIITIS |
131 |
0.0371 |
| 339 |
HAEMODYNAMIC INSTABILITY |
282 |
0.0370 |
| 340 |
CYTOPENIA |
453 |
0.0370 |
| 341 |
SHOCK HAEMORRHAGIC |
300 |
0.0368 |
| 342 |
TREATMENT FAILURE |
3040 |
0.0367 |
| 343 |
OESOPHAGEAL STENOSIS |
103 |
0.0362 |
| 344 |
SKIN HYPERTROPHY |
101 |
0.0359 |
| 345 |
BRAIN HERNIATION |
107 |
0.0358 |
| 346 |
BREAST CANCER STAGE II |
298 |
0.0358 |
| 347 |
POLYARTHRITIS |
187 |
0.0354 |
| 348 |
NECROSIS |
197 |
0.0354 |
| 349 |
DRUG RESISTANCE |
906 |
0.0352 |
| 350 |
GUILLAIN-BARRE SYNDROME |
170 |
0.0351 |
| 351 |
BLOOD CREATININE INCREASED |
2289 |
0.0350 |
| 352 |
FOOT DEFORMITY |
386 |
0.0348 |
| 353 |
ULCER HAEMORRHAGE |
235 |
0.0347 |
| 354 |
RENAL CELL CARCINOMA |
169 |
0.0345 |
| 355 |
ENTEROCOLITIS |
199 |
0.0344 |
| 356 |
RESPIRATORY FAILURE |
2510 |
0.0344 |
| 357 |
PANCYTOPENIA |
1919 |
0.0343 |
| 358 |
INTENTIONAL PRODUCT USE ISSUE |
2979 |
0.0340 |
| 359 |
HEPATIC CIRRHOSIS |
634 |
0.0337 |
| 360 |
NORMOCHROMIC NORMOCYTIC ANAEMIA |
101 |
0.0336 |
| 361 |
NEPHRITIS |
112 |
0.0335 |
| 362 |
HYPERTRANSAMINASAEMIA |
233 |
0.0335 |
| 363 |
STAPHYLOCOCCAL INFECTION |
1103 |
0.0334 |
| 364 |
DYSLIPIDAEMIA |
169 |
0.0332 |
| 365 |
OEDEMA |
1798 |
0.0331 |
| 366 |
MYOSITIS |
297 |
0.0331 |
| 367 |
MUCOSAL INFLAMMATION |
860 |
0.0328 |
| 368 |
HIP ARTHROPLASTY |
503 |
0.0328 |
| 369 |
ANURIA |
281 |
0.0326 |
| 370 |
RENAL IMPAIRMENT |
2741 |
0.0326 |
| 371 |
GAIT INABILITY |
1088 |
0.0325 |
| 372 |
LUNG DISORDER |
1589 |
0.0324 |
| 373 |
ROAD TRAFFIC ACCIDENT |
1354 |
0.0323 |
| 374 |
HEPATITIS B |
195 |
0.0323 |
| 375 |
END STAGE RENAL DISEASE |
590 |
0.0323 |
| 376 |
ENDOPHTHALMITIS |
193 |
0.0321 |
| 377 |
OESOPHAGEAL ULCER |
123 |
0.0320 |
| 378 |
LIVER TRANSPLANT |
115 |
0.0316 |
| 379 |
LUNG INFILTRATION |
279 |
0.0316 |
| 380 |
ACUTE RESPIRATORY FAILURE |
607 |
0.0315 |
| 381 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
111 |
0.0315 |
| 382 |
SEPSIS |
3491 |
0.0313 |
| 383 |
CONTRAINDICATED PRODUCT ADMINISTERED |
947 |
0.0312 |
| 384 |
NIGHT SWEATS |
1005 |
0.0312 |
| 385 |
LIVER DISORDER |
1379 |
0.0311 |
| 386 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
532 |
0.0310 |
| 387 |
DRUG LEVEL ABOVE THERAPEUTIC |
142 |
0.0310 |
| 388 |
NEUROTOXICITY |
542 |
0.0309 |
| 389 |
HYPERURICAEMIA |
127 |
0.0309 |
| 390 |
HAEMOLYTIC ANAEMIA |
276 |
0.0308 |
| 391 |
HAEMODIALYSIS |
256 |
0.0305 |
| 392 |
AUTOIMMUNE HEPATITIS |
212 |
0.0305 |
| 393 |
LOWER RESPIRATORY TRACT INFECTION |
1380 |
0.0303 |
| 394 |
MULTI-ORGAN FAILURE |
521 |
0.0301 |
| 395 |
DISSEMINATED INTRAVASCULAR COAGULATION |
421 |
0.0299 |
| 396 |
PRODUCT USE IN UNAPPROVED INDICATION |
7406 |
0.0299 |
| 397 |
INFUSION RELATED REACTION |
1979 |
0.0298 |
| 398 |
PULMONARY FUNCTION TEST DECREASED |
130 |
0.0297 |
| 399 |
TUBULOINTERSTITIAL NEPHRITIS |
556 |
0.0296 |
| 400 |
RALES |
172 |
0.0296 |
| 401 |
GLUCOSE TOLERANCE IMPAIRED |
175 |
0.0296 |
| 402 |
DRUG INTOLERANCE |
2855 |
0.0295 |
| 403 |
AZOTAEMIA |
118 |
0.0295 |
| 404 |
LEFT VENTRICULAR HYPERTROPHY |
125 |
0.0292 |
| 405 |
ODYNOPHAGIA |
173 |
0.0290 |
| 406 |
URINARY TRACT DISORDER |
130 |
0.0288 |
| 407 |
REBOUND EFFECT |
325 |
0.0287 |
| 408 |
DISEASE RECURRENCE |
1366 |
0.0287 |
| 409 |
ASCITES |
844 |
0.0287 |
| 410 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
248 |
0.0285 |
| 411 |
CARDIAC TAMPONADE |
135 |
0.0284 |
| 412 |
OSTEOARTHRITIS |
1204 |
0.0284 |
| 413 |
HYPERCALCAEMIA |
350 |
0.0283 |
| 414 |
BLOOD PRESSURE DIASTOLIC INCREASED |
130 |
0.0281 |
| 415 |
BLOOD CREATININE ABNORMAL |
97 |
0.0280 |
| 416 |
C-REACTIVE PROTEIN INCREASED |
1019 |
0.0280 |
| 417 |
INFLAMMATION |
1437 |
0.0278 |
| 418 |
CACHEXIA |
143 |
0.0278 |
| 419 |
SPONDYLITIS |
101 |
0.0277 |
| 420 |
VASCULITIS |
323 |
0.0277 |
| 421 |
INFECTION |
3995 |
0.0276 |
| 422 |
PYODERMA GANGRENOSUM |
99 |
0.0275 |
| 423 |
HEPATITIS CHOLESTATIC |
165 |
0.0274 |
| 424 |
BASAL CELL CARCINOMA |
427 |
0.0273 |
| 425 |
BLOOD CHOLESTEROL INCREASED |
1272 |
0.0273 |
| 426 |
MENINGITIS |
182 |
0.0272 |
| 427 |
STOMATITIS |
1644 |
0.0271 |
| 428 |
HYPERAMMONAEMIA |
135 |
0.0270 |
| 429 |
SUBCUTANEOUS ABSCESS |
129 |
0.0269 |
| 430 |
HEPATOCELLULAR CARCINOMA |
204 |
0.0268 |
| 431 |
GENERALISED OEDEMA |
332 |
0.0268 |
| 432 |
HEPATIC ENZYME INCREASED |
1813 |
0.0266 |
| 433 |
FUNGAL INFECTION |
884 |
0.0265 |
| 434 |
MENINGITIS ASEPTIC |
119 |
0.0265 |
| 435 |
POSTOPERATIVE WOUND INFECTION |
179 |
0.0265 |
| 436 |
BONE MARROW FAILURE |
538 |
0.0264 |
| 437 |
CANDIDIASIS |
106 |
0.0264 |
| 438 |
PULMONARY HAEMORRHAGE |
206 |
0.0263 |
| 439 |
HYPERBILIRUBINAEMIA |
272 |
0.0262 |
| 440 |
SPLENOMEGALY |
306 |
0.0261 |
| 441 |
SKIN NECROSIS |
135 |
0.0260 |
| 442 |
ENCEPHALOPATHY |
638 |
0.0260 |
| 443 |
ACUTE KIDNEY INJURY |
3956 |
0.0258 |
| 444 |
UVEITIS |
349 |
0.0257 |
| 445 |
GASTROINTESTINAL TOXICITY |
123 |
0.0256 |
| 446 |
INTERSTITIAL LUNG DISEASE |
1238 |
0.0255 |
| 447 |
URINE OUTPUT DECREASED |
222 |
0.0254 |
| 448 |
BLEPHAROSPASM |
159 |
0.0252 |
| 449 |
WHEEZING |
1492 |
0.0251 |
| 450 |
HYPOALBUMINAEMIA |
195 |
0.0251 |
| 451 |
OSTEOPOROSIS |
1029 |
0.0250 |
| 452 |
GASTROINTESTINAL DISORDER |
2229 |
0.0249 |
| 453 |
PROTEIN URINE PRESENT |
124 |
0.0248 |
| 454 |
DELIRIUM |
862 |
0.0248 |
| 455 |
LARGE INTESTINE PERFORATION |
171 |
0.0246 |
| 456 |
BLISTER |
1382 |
0.0246 |
| 457 |
INTRACRANIAL PRESSURE INCREASED |
137 |
0.0246 |
| 458 |
PNEUMONIA ASPIRATION |
611 |
0.0244 |
| 459 |
ARTHROPATHY |
1358 |
0.0244 |
| 460 |
NEPHROPATHY |
227 |
0.0243 |
| 461 |
FAILURE TO THRIVE |
126 |
0.0242 |
| 462 |
LUNG INFECTION |
376 |
0.0242 |
| 463 |
DRUG TOLERANCE |
122 |
0.0241 |
| 464 |
SKIN INFECTION |
269 |
0.0240 |
| 465 |
HYPERTRIGLYCERIDAEMIA |
140 |
0.0239 |
| 466 |
JOINT STIFFNESS |
623 |
0.0237 |
| 467 |
MUSCULOSKELETAL PAIN |
1243 |
0.0237 |
| 468 |
HYPERKALAEMIA |
832 |
0.0237 |
| 469 |
STREPTOCOCCAL INFECTION |
132 |
0.0237 |
| 470 |
BLOOD CREATINE INCREASED |
105 |
0.0237 |
| 471 |
PREGNANCY |
474 |
0.0236 |
| 472 |
PERICARDIAL EFFUSION |
547 |
0.0236 |
| 473 |
COLITIS |
895 |
0.0236 |
| 474 |
GASTROENTERITIS |
343 |
0.0235 |
| 475 |
TOXIC ENCEPHALOPATHY |
119 |
0.0235 |
| 476 |
HAEMOLYSIS |
180 |
0.0233 |
| 477 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
239 |
0.0233 |
| 478 |
OFF LABEL USE |
20291 |
0.0231 |
| 479 |
CHOLESTASIS |
444 |
0.0231 |
| 480 |
HYPERLIPIDAEMIA |
275 |
0.0230 |
| 481 |
HYDROCEPHALUS |
125 |
0.0229 |
| 482 |
GLOMERULAR FILTRATION RATE DECREASED |
281 |
0.0228 |
| 483 |
MOBILITY DECREASED |
1642 |
0.0228 |
| 484 |
HERPES ZOSTER |
1311 |
0.0228 |
| 485 |
ACUTE HEPATIC FAILURE |
307 |
0.0224 |
| 486 |
CARDIAC FAILURE ACUTE |
148 |
0.0222 |
| 487 |
DRUG LEVEL DECREASED |
226 |
0.0222 |
| 488 |
MOUTH ULCERATION |
467 |
0.0221 |
| 489 |
KNEE ARTHROPLASTY |
465 |
0.0221 |
| 490 |
ANGIOPATHY |
123 |
0.0219 |
| 491 |
HAEMATURIA |
751 |
0.0219 |
| 492 |
RASH VESICULAR |
106 |
0.0219 |
| 493 |
ILL-DEFINED DISORDER |
1317 |
0.0217 |
| 494 |
ADRENAL INSUFFICIENCY |
263 |
0.0217 |
| 495 |
BLOOD ALBUMIN DECREASED |
171 |
0.0215 |
| 496 |
IMMUNODEFICIENCY |
321 |
0.0215 |
| 497 |
ACIDOSIS |
164 |
0.0214 |
| 498 |
DEVICE RELATED INFECTION |
330 |
0.0214 |
| 499 |
METASTASES TO LYMPH NODES |
144 |
0.0213 |
| 500 |
DRUG INTERACTION |
3371 |
0.0212 |
| 501 |
PERITONITIS |
438 |
0.0211 |
| 502 |
PULMONARY MASS |
315 |
0.0211 |
| 503 |
APHTHOUS ULCER |
164 |
0.0211 |
| 504 |
CHRONIC MYELOID LEUKAEMIA |
97 |
0.0210 |
| 505 |
BLOOD PRESSURE SYSTOLIC INCREASED |
409 |
0.0210 |
| 506 |
TYPE 1 DIABETES MELLITUS |
126 |
0.0209 |
| 507 |
HAEMORRHAGIC STROKE |
163 |
0.0209 |
| 508 |
SKIN MASS |
139 |
0.0208 |
| 509 |
INJURY |
1463 |
0.0208 |
| 510 |
DRUG-INDUCED LIVER INJURY |
652 |
0.0208 |
| 511 |
OESOPHAGITIS |
226 |
0.0207 |
| 512 |
SINUSITIS |
2120 |
0.0207 |
| 513 |
DISCOMFORT |
1259 |
0.0206 |
| 514 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
924 |
0.0206 |
| 515 |
BLOOD PRESSURE DIASTOLIC DECREASED |
152 |
0.0206 |
| 516 |
PLEURISY |
122 |
0.0205 |
| 517 |
CLOSTRIDIUM DIFFICILE INFECTION |
443 |
0.0203 |
| 518 |
SKIN LESION |
555 |
0.0202 |
| 519 |
HEPATOTOXICITY |
450 |
0.0202 |
| 520 |
COVID-19 |
3542 |
0.0202 |
| 521 |
BRAIN OEDEMA |
255 |
0.0202 |
| 522 |
ATELECTASIS |
195 |
0.0202 |
| 523 |
HYPOVOLAEMIA |
118 |
0.0201 |
| 524 |
MYOCARDITIS |
231 |
0.0201 |
| 525 |
MALABSORPTION |
105 |
0.0201 |
| 526 |
HAEMATOTOXICITY |
191 |
0.0201 |
| 527 |
RESPIRATORY DISTRESS |
554 |
0.0201 |
| 528 |
MATERNAL EXPOSURE DURING PREGNANCY |
1769 |
0.0198 |
| 529 |
EAR INFECTION |
528 |
0.0198 |
| 530 |
NEUTROPENIA |
2685 |
0.0197 |
| 531 |
RHEUMATOID ARTHRITIS |
2223 |
0.0196 |
| 532 |
MULTIPLE ALLERGIES |
153 |
0.0195 |
| 533 |
HYPOXIA |
679 |
0.0193 |
| 534 |
FEBRILE NEUTROPENIA |
1270 |
0.0191 |
| 535 |
NORMAL NEWBORN |
104 |
0.0191 |
| 536 |
RESPIRATORY TRACT INFECTION |
498 |
0.0191 |
| 537 |
ACUTE MYELOID LEUKAEMIA |
296 |
0.0190 |
| 538 |
BLOOD UREA INCREASED |
318 |
0.0190 |
| 539 |
GASTROINTESTINAL INFECTION |
170 |
0.0189 |
| 540 |
RESPIRATORY DISORDER |
566 |
0.0189 |
| 541 |
UPPER RESPIRATORY TRACT INFECTION |
872 |
0.0189 |
| 542 |
CARDIOGENIC SHOCK |
270 |
0.0188 |
| 543 |
THROMBOCYTOPENIA |
2099 |
0.0188 |
| 544 |
NAIL DISORDER |
164 |
0.0187 |
| 545 |
ORAL DISORDER |
137 |
0.0187 |
| 546 |
COAGULOPATHY |
311 |
0.0186 |
| 547 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2158 |
0.0186 |
| 548 |
MALNUTRITION |
208 |
0.0186 |
| 549 |
LIVER FUNCTION TEST INCREASED |
398 |
0.0185 |
| 550 |
ABSCESS |
295 |
0.0185 |
| 551 |
PNEUMOTHORAX |
293 |
0.0185 |
| 552 |
SWELLING |
1715 |
0.0183 |
| 553 |
METABOLIC ACIDOSIS |
583 |
0.0182 |
| 554 |
TRANSAMINASES INCREASED |
405 |
0.0182 |
| 555 |
EAR PAIN |
354 |
0.0182 |
| 556 |
NEUROLOGICAL SYMPTOM |
104 |
0.0182 |
| 557 |
HEPATIC FAILURE |
547 |
0.0181 |
| 558 |
BLOOD BILIRUBIN INCREASED |
490 |
0.0181 |
| 559 |
DIARRHOEA HAEMORRHAGIC |
168 |
0.0180 |
| 560 |
STATUS EPILEPTICUS |
202 |
0.0179 |
| 561 |
HEPATITIS |
457 |
0.0178 |
| 562 |
INTESTINAL ISCHAEMIA |
98 |
0.0178 |
| 563 |
OSTEOMYELITIS |
322 |
0.0178 |
| 564 |
JOINT SWELLING |
2140 |
0.0177 |
| 565 |
RENAL FAILURE CHRONIC |
136 |
0.0177 |
| 566 |
PEMPHIGOID |
132 |
0.0175 |
| 567 |
PULMONARY HYPERTENSION |
363 |
0.0174 |
| 568 |
SHOCK |
397 |
0.0172 |
| 569 |
GASTRIC ULCER |
327 |
0.0172 |
| 570 |
ORAL CANDIDIASIS |
226 |
0.0171 |
| 571 |
MUSCULOSKELETAL STIFFNESS |
1499 |
0.0171 |
| 572 |
HYPOMAGNESAEMIA |
238 |
0.0171 |
| 573 |
PNEUMONIA |
5505 |
0.0170 |
| 574 |
HAEMORRHAGE INTRACRANIAL |
253 |
0.0169 |
| 575 |
SKIN ULCER |
437 |
0.0169 |
| 576 |
PYREXIA |
5821 |
0.0168 |
| 577 |
IRON DEFICIENCY ANAEMIA |
155 |
0.0168 |
| 578 |
CORONAVIRUS INFECTION |
111 |
0.0168 |
| 579 |
DUODENAL ULCER |
117 |
0.0166 |
| 580 |
HYPERTENSION |
3503 |
0.0165 |
| 581 |
PLEURAL EFFUSION |
1004 |
0.0165 |
| 582 |
VIRAL INFECTION |
549 |
0.0165 |
| 583 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
261 |
0.0165 |
| 584 |
PAPULE |
115 |
0.0163 |
| 585 |
DRY MOUTH |
1323 |
0.0163 |
| 586 |
DIABETES MELLITUS |
1242 |
0.0163 |
| 587 |
LIVER FUNCTION TEST ABNORMAL |
473 |
0.0162 |
| 588 |
JOINT EFFUSION |
112 |
0.0162 |
| 589 |
COMA |
772 |
0.0162 |
| 590 |
EXPOSURE DURING PREGNANCY |
1006 |
0.0162 |
| 591 |
METASTASES TO LUNG |
187 |
0.0162 |
| 592 |
NEUTROPENIC SEPSIS |
114 |
0.0159 |
| 593 |
DYSPNOEA EXERTIONAL |
598 |
0.0159 |
| 594 |
LEUKOCYTOSIS |
287 |
0.0158 |
| 595 |
PANCREATITIS ACUTE |
355 |
0.0158 |
| 596 |
METASTASIS |
112 |
0.0157 |
| 597 |
HEPATOMEGALY |
154 |
0.0157 |
| 598 |
DIPLOPIA |
406 |
0.0156 |
| 599 |
SLEEP DISORDER |
1095 |
0.0155 |
| 600 |
HEPATIC ENCEPHALOPATHY |
144 |
0.0154 |
| 601 |
RENAL FAILURE |
2048 |
0.0154 |
| 602 |
RIGHT VENTRICULAR FAILURE |
107 |
0.0153 |
| 603 |
CONDITION AGGRAVATED |
4626 |
0.0152 |
| 604 |
MITRAL VALVE INCOMPETENCE |
172 |
0.0152 |
| 605 |
RENAL FAILURE ACUTE |
634 |
0.0149 |
| 606 |
OSTEOPENIA |
226 |
0.0149 |
| 607 |
HEMIPARESIS |
252 |
0.0149 |
| 608 |
ARTERIOSCLEROSIS |
139 |
0.0148 |
| 609 |
DIALYSIS |
208 |
0.0146 |
| 610 |
HYPOPHOSPHATAEMIA |
108 |
0.0146 |
| 611 |
ANAEMIA |
2786 |
0.0146 |
| 612 |
BLOOD PRESSURE FLUCTUATION |
350 |
0.0146 |
| 613 |
PNEUMONITIS |
396 |
0.0145 |
| 614 |
CELLULITIS |
731 |
0.0145 |
| 615 |
URINARY TRACT INFECTION |
2456 |
0.0144 |
| 616 |
CONTUSION |
1386 |
0.0144 |
| 617 |
PURPURA |
127 |
0.0143 |
| 618 |
MYELODYSPLASTIC SYNDROME |
207 |
0.0143 |
| 619 |
PRODUCT PRESCRIBING ISSUE |
311 |
0.0143 |
| 620 |
HAEMATOCRIT DECREASED |
283 |
0.0143 |
| 621 |
EPILEPSY |
436 |
0.0142 |
| 622 |
EYELID PTOSIS |
144 |
0.0142 |
| 623 |
HYPERGLYCAEMIA |
516 |
0.0141 |
| 624 |
ULCER |
225 |
0.0141 |
| 625 |
ORAL HERPES |
275 |
0.0141 |
| 626 |
SUBARACHNOID HAEMORRHAGE |
143 |
0.0140 |
| 627 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
124 |
0.0140 |
| 628 |
ILEUS |
174 |
0.0140 |
| 629 |
MALIGNANT MELANOMA |
187 |
0.0139 |
| 630 |
ALTERED STATE OF CONSCIOUSNESS |
302 |
0.0139 |
| 631 |
OSTEONECROSIS |
457 |
0.0139 |
| 632 |
HEPATIC FUNCTION ABNORMAL |
516 |
0.0138 |
| 633 |
DISEASE PROGRESSION |
1627 |
0.0137 |
| 634 |
LOW BIRTH WEIGHT BABY |
109 |
0.0137 |
| 635 |
INFLAMMATORY BOWEL DISEASE |
134 |
0.0137 |
| 636 |
MYOCLONUS |
163 |
0.0137 |
| 637 |
OEDEMA PERIPHERAL |
1665 |
0.0136 |
| 638 |
AMNESIA |
883 |
0.0136 |
| 639 |
LYMPHADENOPATHY |
479 |
0.0135 |
| 640 |
HYPOAESTHESIA |
2023 |
0.0135 |
| 641 |
DISABILITY |
267 |
0.0135 |
| 642 |
TRICUSPID VALVE INCOMPETENCE |
107 |
0.0135 |
| 643 |
MENTAL STATUS CHANGES |
374 |
0.0135 |
| 644 |
INFUSION SITE PAIN |
173 |
0.0134 |
| 645 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
228 |
0.0134 |
| 646 |
LYMPHOMA |
205 |
0.0133 |
| 647 |
HEPATOCELLULAR INJURY |
188 |
0.0132 |
| 648 |
PULMONARY ARTERIAL HYPERTENSION |
191 |
0.0132 |
| 649 |
CENTRAL NERVOUS SYSTEM LESION |
181 |
0.0132 |
| 650 |
OXYGEN SATURATION DECREASED |
740 |
0.0132 |
| 651 |
TOXICITY TO VARIOUS AGENTS |
2211 |
0.0131 |
| 652 |
PREMATURE DELIVERY |
208 |
0.0130 |
| 653 |
FACIAL PARALYSIS |
111 |
0.0130 |
| 654 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
380 |
0.0130 |
| 655 |
SMALL INTESTINAL OBSTRUCTION |
159 |
0.0129 |
| 656 |
RESPIRATORY RATE INCREASED |
114 |
0.0128 |
| 657 |
OPTIC NEURITIS |
116 |
0.0128 |
| 658 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
316 |
0.0127 |
| 659 |
MUSCULAR WEAKNESS |
1446 |
0.0127 |
| 660 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
280 |
0.0126 |
| 661 |
GENERALISED TONIC-CLONIC SEIZURE |
208 |
0.0126 |
| 662 |
MUSCLE ATROPHY |
159 |
0.0125 |
| 663 |
WEIGHT FLUCTUATION |
130 |
0.0124 |
| 664 |
THERAPEUTIC RESPONSE DECREASED |
750 |
0.0124 |
| 665 |
FLUID OVERLOAD |
180 |
0.0124 |
| 666 |
CARDIOMYOPATHY |
182 |
0.0123 |
| 667 |
FREQUENT BOWEL MOVEMENTS |
332 |
0.0123 |
| 668 |
PANCREATITIS |
644 |
0.0122 |
| 669 |
ABDOMINAL DISCOMFORT |
2042 |
0.0122 |
| 670 |
BLINDNESS |
496 |
0.0122 |
| 671 |
PHOTOSENSITIVITY REACTION |
200 |
0.0121 |
| 672 |
SKIN CANCER |
258 |
0.0120 |
| 673 |
DIVERTICULITIS |
331 |
0.0119 |
| 674 |
ALOPECIA |
2326 |
0.0118 |
| 675 |
GOUT |
212 |
0.0118 |
| 676 |
COLITIS ULCERATIVE |
522 |
0.0117 |
| 677 |
CONFUSIONAL STATE |
1884 |
0.0116 |
| 678 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
553 |
0.0115 |
| 679 |
WHITE BLOOD CELL COUNT INCREASED |
441 |
0.0115 |
| 680 |
INTESTINAL PERFORATION |
129 |
0.0115 |
| 681 |
PHOTOPHOBIA |
214 |
0.0114 |
| 682 |
WEIGHT INCREASED |
2543 |
0.0113 |
| 683 |
PULMONARY OEDEMA |
504 |
0.0112 |
| 684 |
TACHYPNOEA |
153 |
0.0112 |
| 685 |
OCULAR DISCOMFORT |
126 |
0.0112 |
| 686 |
ARTHRITIS |
879 |
0.0112 |
| 687 |
CEREBRAL INFARCTION |
273 |
0.0112 |
| 688 |
ALANINE AMINOTRANSFERASE INCREASED |
686 |
0.0112 |
| 689 |
PERIPHERAL SWELLING |
1717 |
0.0111 |
| 690 |
DIARRHOEA |
7190 |
0.0111 |
| 691 |
TUMOUR LYSIS SYNDROME |
98 |
0.0111 |
| 692 |
ELECTROLYTE IMBALANCE |
129 |
0.0111 |
| 693 |
CATARACT |
660 |
0.0111 |
| 694 |
RENAL DISORDER |
516 |
0.0111 |
| 695 |
MYELOSUPPRESSION |
398 |
0.0110 |
| 696 |
NEOPLASM |
127 |
0.0110 |
| 697 |
HAEMATOMA |
285 |
0.0110 |
| 698 |
FLANK PAIN |
103 |
0.0110 |
| 699 |
DYSPEPSIA |
1063 |
0.0108 |
| 700 |
KIDNEY INFECTION |
211 |
0.0107 |
| 701 |
ATAXIA |
127 |
0.0107 |
| 702 |
PRODUCTIVE COUGH |
510 |
0.0107 |
| 703 |
TACHYCARDIA |
949 |
0.0107 |
| 704 |
DECREASED APPETITE |
2472 |
0.0106 |
| 705 |
GLAUCOMA |
204 |
0.0106 |
| 706 |
DRUG TOXICITY |
144 |
0.0106 |
| 707 |
TREATMENT NONCOMPLIANCE |
577 |
0.0105 |
| 708 |
LABORATORY TEST ABNORMAL |
309 |
0.0105 |
| 709 |
ASTHMA |
1183 |
0.0105 |
| 710 |
GASTRITIS |
275 |
0.0104 |
| 711 |
CARDIOMEGALY |
128 |
0.0104 |
| 712 |
HAEMOPTYSIS |
289 |
0.0104 |
| 713 |
NEUTROPHIL COUNT INCREASED |
106 |
0.0103 |
| 714 |
HEPATIC CYTOLYSIS |
131 |
0.0103 |
| 715 |
SEASONAL ALLERGY |
145 |
0.0102 |
| 716 |
DIABETIC KETOACIDOSIS |
246 |
0.0102 |
| 717 |
HAEMOGLOBIN DECREASED |
1050 |
0.0102 |
| 718 |
WEIGHT DECREASED |
2850 |
0.0102 |
| 719 |
ABDOMINAL PAIN |
2372 |
0.0102 |
| 720 |
ABORTION SPONTANEOUS |
408 |
0.0102 |
| 721 |
CIRCULATORY COLLAPSE |
173 |
0.0101 |
| 722 |
CHRONIC KIDNEY DISEASE |
771 |
0.0101 |
| 723 |
CARDIAC FAILURE |
813 |
0.0101 |
| 724 |
NASOPHARYNGITIS |
1860 |
0.0101 |
| 725 |
CYTOKINE RELEASE SYNDROME |
202 |
0.0101 |
| 726 |
CHEST PAIN |
1855 |
0.0100 |
| 727 |
GASTROOESOPHAGEAL REFLUX DISEASE |
803 |
0.0100 |
| 728 |
PRODUCT USE ISSUE |
1872 |
0.0100 |
| 729 |
HYPONATRAEMIA |
561 |
0.0099 |
| 730 |
MASS |
139 |
0.0099 |
| 731 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
704 |
0.0099 |
| 732 |
HYPERSENSITIVITY |
1824 |
0.0098 |
| 733 |
URTICARIA |
1618 |
0.0096 |
| 734 |
ASPIRATION |
105 |
0.0096 |
| 735 |
PETECHIAE |
100 |
0.0096 |
| 736 |
JAUNDICE |
256 |
0.0095 |
| 737 |
BODY TEMPERATURE INCREASED |
194 |
0.0095 |
| 738 |
HYPOCALCAEMIA |
179 |
0.0094 |
| 739 |
CYSTITIS |
300 |
0.0094 |
| 740 |
POST PROCEDURAL COMPLICATION |
180 |
0.0094 |
| 741 |
BLOOD POTASSIUM INCREASED |
152 |
0.0094 |
| 742 |
CEREBRAL HAEMORRHAGE |
333 |
0.0093 |
| 743 |
RECTAL HAEMORRHAGE |
399 |
0.0093 |
| 744 |
INTRAOCULAR PRESSURE INCREASED |
118 |
0.0092 |
| 745 |
HAEMATEMESIS |
234 |
0.0092 |
| 746 |
POLYNEUROPATHY |
110 |
0.0092 |
| 747 |
LYMPHOCYTE COUNT DECREASED |
162 |
0.0092 |
| 748 |
NERVOUS SYSTEM DISORDER |
286 |
0.0092 |
| 749 |
HEAD DISCOMFORT |
162 |
0.0091 |
| 750 |
ASPARTATE AMINOTRANSFERASE INCREASED |
485 |
0.0091 |
| 751 |
TASTE DISORDER |
184 |
0.0091 |
| 752 |
MEDICATION ERROR |
504 |
0.0091 |
| 753 |
HYPOKALAEMIA |
417 |
0.0090 |
| 754 |
COUGH |
2532 |
0.0090 |
| 755 |
FLUID RETENTION |
458 |
0.0090 |
| 756 |
CARDIAC ARREST |
742 |
0.0090 |
| 757 |
VOMITING |
4210 |
0.0089 |
| 758 |
RASH MACULO-PAPULAR |
198 |
0.0089 |
| 759 |
CHOLECYSTITIS |
106 |
0.0089 |
| 760 |
BRONCHITIS |
656 |
0.0089 |
| 761 |
ABDOMINAL PAIN UPPER |
1821 |
0.0088 |
| 762 |
GASTROINTESTINAL HAEMORRHAGE |
735 |
0.0088 |
| 763 |
DRUG INEFFECTIVE |
11584 |
0.0088 |
| 764 |
PREMATURE BABY |
261 |
0.0087 |
| 765 |
NODULE |
112 |
0.0086 |
| 766 |
VENTRICULAR TACHYCARDIA |
139 |
0.0084 |
| 767 |
PAIN IN JAW |
238 |
0.0084 |
| 768 |
DEEP VEIN THROMBOSIS |
545 |
0.0084 |
| 769 |
MIGRAINE |
797 |
0.0083 |
| 770 |
MELAENA |
182 |
0.0083 |
| 771 |
PARALYSIS |
118 |
0.0082 |
| 772 |
IMMUNE SYSTEM DISORDER |
108 |
0.0082 |
| 773 |
MEMORY IMPAIRMENT |
1112 |
0.0081 |
| 774 |
PLATELET COUNT INCREASED |
105 |
0.0080 |
| 775 |
COLON CANCER |
120 |
0.0080 |
| 776 |
APHASIA |
243 |
0.0080 |
| 777 |
VISUAL IMPAIRMENT |
989 |
0.0080 |
| 778 |
BLINDNESS UNILATERAL |
112 |
0.0079 |
| 779 |
CARDIO-RESPIRATORY ARREST |
332 |
0.0079 |
| 780 |
PLATELET COUNT DECREASED |
843 |
0.0079 |
| 781 |
EYE PAIN |
444 |
0.0079 |
| 782 |
ASTHENIA |
2945 |
0.0078 |
| 783 |
SKIN DISORDER |
261 |
0.0078 |
| 784 |
EOSINOPHILIA |
137 |
0.0078 |
| 785 |
HEPATIC STEATOSIS |
145 |
0.0078 |
| 786 |
DYSPNOEA |
4371 |
0.0077 |
| 787 |
EJECTION FRACTION DECREASED |
120 |
0.0077 |
| 788 |
QUALITY OF LIFE DECREASED |
103 |
0.0077 |
| 789 |
ACNE |
579 |
0.0076 |
| 790 |
NEOPLASM MALIGNANT |
508 |
0.0076 |
| 791 |
GASTROENTERITIS VIRAL |
137 |
0.0076 |
| 792 |
DIABETES MELLITUS INADEQUATE CONTROL |
134 |
0.0076 |
| 793 |
RED BLOOD CELL COUNT DECREASED |
216 |
0.0075 |
| 794 |
PRESYNCOPE |
183 |
0.0075 |
| 795 |
SUBDURAL HAEMATOMA |
107 |
0.0075 |
| 796 |
ARTHRALGIA |
3097 |
0.0074 |
| 797 |
HYPOTENSION |
1476 |
0.0074 |
| 798 |
VISUAL ACUITY REDUCED |
244 |
0.0073 |
| 799 |
RHABDOMYOLYSIS |
306 |
0.0073 |
| 800 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
123 |
0.0073 |
| 801 |
PRODUCT PRESCRIBING ERROR |
174 |
0.0073 |
| 802 |
IMPAIRED QUALITY OF LIFE |
105 |
0.0073 |
| 803 |
RASH |
3182 |
0.0073 |
| 804 |
METASTASES TO LIVER |
127 |
0.0072 |
| 805 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
208 |
0.0072 |
| 806 |
ATRIAL FIBRILLATION |
701 |
0.0072 |
| 807 |
BACK DISORDER |
117 |
0.0072 |
| 808 |
PULMONARY EMBOLISM |
671 |
0.0071 |
| 809 |
DYSPHAGIA |
666 |
0.0070 |
| 810 |
HYPOPHAGIA |
179 |
0.0070 |
| 811 |
ISCHAEMIC STROKE |
124 |
0.0069 |
| 812 |
DEHYDRATION |
920 |
0.0069 |
| 813 |
DYSURIA |
253 |
0.0069 |
| 814 |
INFLUENZA |
764 |
0.0068 |
| 815 |
ACUTE MYOCARDIAL INFARCTION |
202 |
0.0068 |
| 816 |
PARAESTHESIA |
1076 |
0.0068 |
| 817 |
HEART RATE DECREASED |
240 |
0.0068 |
| 818 |
MALAISE |
2992 |
0.0068 |
| 819 |
FEELING HOT |
415 |
0.0068 |
| 820 |
BLOOD PRESSURE INCREASED |
1022 |
0.0067 |
| 821 |
LOCALISED INFECTION |
161 |
0.0067 |
| 822 |
HEADACHE |
4134 |
0.0066 |
| 823 |
METASTASES TO BONE |
108 |
0.0066 |
| 824 |
HYPOTHYROIDISM |
209 |
0.0065 |
| 825 |
HEART RATE INCREASED |
645 |
0.0065 |
| 826 |
INSOMNIA |
1701 |
0.0064 |
| 827 |
ADVERSE EVENT |
580 |
0.0063 |
| 828 |
ANAPHYLACTIC REACTION |
347 |
0.0063 |
| 829 |
GAIT DISTURBANCE |
1194 |
0.0062 |
| 830 |
CHILLS |
724 |
0.0062 |
| 831 |
WHITE BLOOD CELL COUNT DECREASED |
668 |
0.0062 |
| 832 |
HERNIA |
119 |
0.0061 |
| 833 |
FATIGUE |
4781 |
0.0061 |
| 834 |
NECK PAIN |
343 |
0.0061 |
| 835 |
POOR QUALITY SLEEP |
132 |
0.0061 |
| 836 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
240 |
0.0061 |
| 837 |
DERMATITIS |
127 |
0.0061 |
| 838 |
RENAL INJURY |
180 |
0.0061 |
| 839 |
DEAFNESS |
158 |
0.0060 |
| 840 |
FOETAL EXPOSURE DURING PREGNANCY |
490 |
0.0060 |
| 841 |
DEPRESSION |
1355 |
0.0059 |
| 842 |
NAUSEA |
4708 |
0.0059 |
| 843 |
CORONARY ARTERY DISEASE |
180 |
0.0059 |
| 844 |
PRURITUS |
2282 |
0.0059 |
| 845 |
MUSCLE SPASMS |
1088 |
0.0059 |
| 846 |
ARRHYTHMIA |
278 |
0.0059 |
| 847 |
SLEEP APNOEA SYNDROME |
111 |
0.0058 |
| 848 |
FOOT FRACTURE |
110 |
0.0058 |
| 849 |
SEIZURE |
669 |
0.0058 |
| 850 |
PSYCHOTIC DISORDER |
171 |
0.0058 |
| 851 |
HALLUCINATION, VISUAL |
121 |
0.0057 |
| 852 |
SCAR |
98 |
0.0057 |
| 853 |
DRUG ERUPTION |
100 |
0.0056 |
| 854 |
PAIN IN EXTREMITY |
1660 |
0.0056 |
| 855 |
TREMOR |
935 |
0.0056 |
| 856 |
DYSARTHRIA |
212 |
0.0056 |
| 857 |
EYE DISORDER |
185 |
0.0056 |
| 858 |
BONE DISORDER |
102 |
0.0056 |
| 859 |
ADVERSE DRUG REACTION |
502 |
0.0056 |
| 860 |
CONJUNCTIVITIS |
103 |
0.0055 |
| 861 |
URINARY RETENTION |
185 |
0.0055 |
| 862 |
DISORIENTATION |
217 |
0.0055 |
| 863 |
RIB FRACTURE |
112 |
0.0054 |
| 864 |
FRACTURE |
103 |
0.0054 |
| 865 |
INTESTINAL OBSTRUCTION |
205 |
0.0054 |
| 866 |
HAEMORRHOIDS |
106 |
0.0054 |
| 867 |
THROAT IRRITATION |
240 |
0.0053 |
| 868 |
EPISTAXIS |
398 |
0.0053 |
| 869 |
ANXIETY |
1505 |
0.0053 |
| 870 |
IMPAIRED WORK ABILITY |
113 |
0.0053 |
| 871 |
NEURALGIA |
128 |
0.0053 |
| 872 |
OROPHARYNGEAL PAIN |
485 |
0.0052 |
| 873 |
BLOOD PRESSURE DECREASED |
348 |
0.0052 |
| 874 |
BLOOD POTASSIUM DECREASED |
157 |
0.0052 |
| 875 |
HAEMORRHAGE |
542 |
0.0052 |
| 876 |
CONVULSION |
295 |
0.0052 |
| 877 |
PLASMA CELL MYELOMA |
201 |
0.0051 |
| 878 |
THROMBOSIS |
414 |
0.0051 |
| 879 |
MYALGIA |
872 |
0.0051 |
| 880 |
UNDERDOSE |
373 |
0.0051 |
| 881 |
LUNG NEOPLASM MALIGNANT |
208 |
0.0051 |
| 882 |
BLOOD PRESSURE ABNORMAL |
98 |
0.0049 |
| 883 |
RASH PRURITIC |
267 |
0.0049 |
| 884 |
ORAL PAIN |
110 |
0.0049 |
| 885 |
CHOLELITHIASIS |
161 |
0.0049 |
| 886 |
NEUROPATHY PERIPHERAL |
466 |
0.0049 |
| 887 |
DIZZINESS |
2440 |
0.0049 |
| 888 |
TINNITUS |
224 |
0.0049 |
| 889 |
PAIN |
2993 |
0.0049 |
| 890 |
HAEMATOCHEZIA |
268 |
0.0049 |
| 891 |
CARDIOVASCULAR DISORDER |
123 |
0.0048 |
| 892 |
MENTAL DISORDER |
210 |
0.0048 |
| 893 |
ANGIOEDEMA |
207 |
0.0047 |
| 894 |
RHINORRHOEA |
302 |
0.0047 |
| 895 |
LETHARGY |
268 |
0.0047 |
| 896 |
ABDOMINAL DISTENSION |
486 |
0.0047 |
| 897 |
NO ADVERSE EVENT |
833 |
0.0046 |
| 898 |
SOMNOLENCE |
920 |
0.0046 |
| 899 |
ABDOMINAL PAIN LOWER |
115 |
0.0045 |
| 900 |
ANGINA PECTORIS |
130 |
0.0045 |
| 901 |
LACTIC ACIDOSIS |
144 |
0.0044 |
| 902 |
BRADYCARDIA |
231 |
0.0044 |
| 903 |
RASH ERYTHEMATOUS |
208 |
0.0043 |
| 904 |
NEPHROLITHIASIS |
199 |
0.0043 |
| 905 |
DRY EYE |
216 |
0.0043 |
| 906 |
SYNCOPE |
425 |
0.0042 |
| 907 |
COGNITIVE DISORDER |
196 |
0.0042 |
| 908 |
BONE DENSITY DECREASED |
131 |
0.0042 |
| 909 |
GASTRIC DISORDER |
143 |
0.0042 |
| 910 |
LIMB INJURY |
113 |
0.0042 |
| 911 |
UNRESPONSIVE TO STIMULI |
107 |
0.0041 |
| 912 |
SPEECH DISORDER |
216 |
0.0041 |
| 913 |
NASAL CONGESTION |
242 |
0.0041 |
| 914 |
PALLOR |
111 |
0.0041 |
| 915 |
NEUTROPHIL COUNT DECREASED |
163 |
0.0040 |
| 916 |
PSORIASIS |
522 |
0.0040 |
| 917 |
DEATH |
3389 |
0.0039 |
| 918 |
ILLNESS |
400 |
0.0039 |
| 919 |
LOSS OF CONSCIOUSNESS |
496 |
0.0039 |
| 920 |
THERAPEUTIC RESPONSE SHORTENED |
127 |
0.0038 |
| 921 |
HIP FRACTURE |
123 |
0.0038 |
| 922 |
HOSPITALISATION |
585 |
0.0038 |
| 923 |
DYSPHONIA |
222 |
0.0038 |
| 924 |
CEREBROVASCULAR ACCIDENT |
636 |
0.0038 |
| 925 |
URINARY INCONTINENCE |
111 |
0.0037 |
| 926 |
HYPOGLYCAEMIA |
179 |
0.0037 |
| 927 |
CHEST DISCOMFORT |
372 |
0.0036 |
| 928 |
BACK PAIN |
832 |
0.0036 |
| 929 |
VERTIGO |
218 |
0.0036 |
| 930 |
VISION BLURRED |
485 |
0.0035 |
| 931 |
INTERNATIONAL NORMALISED RATIO INCREASED |
99 |
0.0035 |
| 932 |
ACCIDENTAL OVERDOSE |
127 |
0.0035 |
| 933 |
FALL |
1151 |
0.0035 |
| 934 |
ERYTHEMA |
703 |
0.0034 |
| 935 |
DRUG EFFECT INCOMPLETE |
123 |
0.0034 |
| 936 |
CARDIAC FAILURE CONGESTIVE |
272 |
0.0034 |
| 937 |
DRUG EXPOSURE DURING PREGNANCY |
113 |
0.0033 |
| 938 |
SWELLING FACE |
216 |
0.0033 |
| 939 |
MOVEMENT DISORDER |
105 |
0.0033 |
| 940 |
SURGERY |
191 |
0.0033 |
| 941 |
LIMB DISCOMFORT |
100 |
0.0032 |
| 942 |
CARDIAC DISORDER |
301 |
0.0032 |
| 943 |
POLLAKIURIA |
134 |
0.0032 |
| 944 |
SKIN DISCOLOURATION |
147 |
0.0032 |
| 945 |
INTENTIONAL PRODUCT MISUSE |
276 |
0.0031 |
| 946 |
DISTURBANCE IN ATTENTION |
167 |
0.0031 |
| 947 |
DEPRESSED MOOD |
162 |
0.0031 |
| 948 |
AGITATION |
223 |
0.0030 |
| 949 |
ECZEMA |
157 |
0.0030 |
| 950 |
MYOCARDIAL INFARCTION |
514 |
0.0029 |
| 951 |
PALPITATIONS |
341 |
0.0029 |
| 952 |
TRANSIENT ISCHAEMIC ATTACK |
98 |
0.0029 |
| 953 |
THERAPY INTERRUPTED |
207 |
0.0029 |
| 954 |
HALLUCINATION |
216 |
0.0029 |
| 955 |
BLOOD GLUCOSE INCREASED |
535 |
0.0028 |
| 956 |
OVERDOSE |
577 |
0.0027 |
| 957 |
THERAPY CESSATION |
136 |
0.0026 |
| 958 |
BURNING SENSATION |
184 |
0.0026 |
| 959 |
BALANCE DISORDER |
218 |
0.0025 |
| 960 |
BONE PAIN |
145 |
0.0025 |
| 961 |
INFLUENZA LIKE ILLNESS |
202 |
0.0025 |
| 962 |
SKIN EXFOLIATION |
207 |
0.0025 |
| 963 |
DYSKINESIA |
99 |
0.0024 |
| 964 |
FLUSHING |
239 |
0.0023 |
| 965 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
418 |
0.0023 |
| 966 |
CONSTIPATION |
487 |
0.0022 |
| 967 |
UNEVALUABLE EVENT |
163 |
0.0022 |
| 968 |
DERMATITIS ATOPIC |
113 |
0.0021 |
| 969 |
HYPERHIDROSIS |
272 |
0.0021 |
| 970 |
OCULAR HYPERAEMIA |
100 |
0.0021 |
| 971 |
PROSTATE CANCER |
166 |
0.0021 |
| 972 |
MALIGNANT NEOPLASM PROGRESSION |
211 |
0.0021 |
| 973 |
PRODUCT DOSE OMISSION ISSUE |
595 |
0.0020 |
| 974 |
FLATULENCE |
114 |
0.0020 |
| 975 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
102 |
0.0020 |
| 976 |
IRRITABILITY |
115 |
0.0019 |
| 977 |
FEELING ABNORMAL |
454 |
0.0019 |
| 978 |
BREAST CANCER |
172 |
0.0018 |
| 979 |
SUICIDAL IDEATION |
154 |
0.0017 |
| 980 |
DYSGEUSIA |
119 |
0.0016 |
| 981 |
HOT FLUSH |
118 |
0.0016 |
| 982 |
PRODUCT QUALITY ISSUE |
198 |
0.0015 |
| 983 |
EMOTIONAL DISTRESS |
176 |
0.0015 |
| 984 |
DRY SKIN |
187 |
0.0014 |
| 985 |
DRUG DOSE OMISSION |
224 |
0.0014 |
| 986 |
INCORRECT DOSE ADMINISTERED |
303 |
0.0013 |
| 987 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
189 |
0.0009 |
| 988 |
DRUG DEPENDENCE |
125 |
0.0008 |
| 989 |
INJECTION SITE PAIN |
187 |
0.0006 |